Published in Respiration on December 18, 2008
Induced sputum as a method for detection of systemic sclerosis-related interstitial lung disease. Rheumatol Int (2011) 0.76
Sleep patterns in patients with acute coronary syndromes. Sleep Med (2010) 1.74
Is a miliary chest pattern always indicative of tuberculosis or malignancy? Respiration (2006) 1.67
Induced sputum versus bronchoalveolar lavage fluid in the evaluation of patients with idiopathic pulmonary fibrosis. Respiration (2005) 1.44
Smoking-related emphysema is associated with idiopathic pulmonary fibrosis and rheumatoid lung. Respirology (2013) 1.43
Exhaled breath condensate 8-isoprostane, clinical parameters, radiological indices and airway inflammation in COPD. Respiration (2007) 1.42
Idiopathic pulmonary fibrosis: outcome in relation to smoking status. Am J Respir Crit Care Med (2007) 1.41
Perforin expression and cytotoxic activity of sputum CD8+ lymphocytes in patients with COPD. Chest (2004) 1.39
Expression of apoptotic and antiapoptotic markers in epithelial cells in idiopathic pulmonary fibrosis. Chest (2005) 1.39
Apoptotic mechanisms in the pathogenesis of COPD. Int J Chron Obstruct Pulmon Dis (2006) 1.31
Atrial overdrive pacing for the obstructive sleep apnea-hypopnea syndrome. N Engl J Med (2005) 1.26
Dyspnea assessment and adverse events during sputum induction in COPD. BMC Pulm Med (2006) 1.15
Sleep disordered breathing in patients with acute coronary syndromes. J Clin Sleep Med (2012) 1.14
Non-specific interstitial pneumonia in cigarette smokers: a CT study. Eur Radiol (2009) 1.13
Preventing exacerbations of COPD--advice from Hippocrates. N Engl J Med (2011) 1.11
Isolation of myeloid and plasmacytoid dendritic cells from human bronchoalveolar lavage fluid. Immunol Cell Biol (2006) 1.10
Role of angiogenesis and vascular remodeling in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2007) 1.06
The pathogenesis of pulmonary fibrosis: a moving target. Eur Respir J (2012) 1.03
Different angiogenic activity in pulmonary sarcoidosis and idiopathic pulmonary fibrosis. Chest (2006) 1.02
Association between heat shock protein 70/Hom genetic polymorphisms and uveitis in patients with sarcoidosis. Invest Ophthalmol Vis Sci (2007) 1.00
CPAP therapy in patients with idiopathic pulmonary fibrosis and obstructive sleep apnea: does it offer a better quality of life and sleep? Sleep Breath (2013) 0.98
Clinical presentation and management of empyema, lung abscess and pleural effusion. Curr Opin Pulm Med (2006) 0.98
Prognostic value of serum tumor markers in patients with lung cancer. Respiration (2002) 0.96
Induced sputum CD8+ T-lymphocyte subpopulations in chronic obstructive pulmonary disease. Respir Med (2004) 0.95
Is there any correlation between the ATS, BTS, ERS and GOLD COPD's severity scales and the frequency of hospital admissions? Respir Med (2004) 0.94
Intrapleural streptokinase for pleural infection. BMJ (2006) 0.94
The relationships among hydrogen peroxide in expired breath condensate, airway inflammation, and asthma severity. Chest (2002) 0.94
Nitrosative stress, heme oxygenase-1 expression and airway inflammation during severe exacerbations of COPD. Chest (2005) 0.93
Expression profiles of Toll-like receptors in non-small cell lung cancer and idiopathic pulmonary fibrosis. Int J Oncol (2012) 0.93
Decreased small airway and alveolar CD83+ dendritic cells in COPD. Chest (2009) 0.93
Upregulation of Th1 cytokine profile (IL-12, IL-18) in bronchoalveolar lavage fluid in patients with pulmonary sarcoidosis. J Interferon Cytokine Res (2006) 0.92
Smoking and pulmonary fibrosis: novel insights. Pulm Med (2011) 0.92
The clinical significance of serum and bronchoalveolar lavage inflammatory cytokines in patients at risk for Acute Respiratory Distress Syndrome. BMC Pulm Med (2004) 0.92
Pathogenetic pathways and novel pharmacotherapeutic targets in idiopathic pulmonary fibrosis. Pulm Pharmacol Ther (2006) 0.92
Severe airway stenosis associated with Crohn's disease: case report. BMC Pulm Med (2006) 0.92
Exhaled H(2)O(2) in steady-state bronchiectasis: relationship with cellular composition in induced sputum, spirometry, and extent and severity of disease. Chest (2002) 0.91
Deregulation of apoptosis mediators' p53 and bcl2 in lung tissue of COPD patients. Respir Res (2010) 0.91
Asthma in the Elderly: Can We Distinguish It from COPD? J Allergy (Cairo) (2011) 0.90
Changes in sputum T-lymphocyte subpopulations at the onset of severe exacerbations of chronic obstructive pulmonary disease. Respir Med (2004) 0.90
Interferon-gamma 1b for the treatment of idiopathic pulmonary fibrosis. Expert Opin Biol Ther (2006) 0.90
Air travel for patients with chronic obstructive pulmonary disease: a case report. Br J Gen Pract (2012) 0.90
Expression analysis of angiogenic growth factors and biological axis CXCL12/CXCR4 axis in idiopathic pulmonary fibrosis. Connect Tissue Res (2010) 0.90
Biomarkers in COPD. Curr Med Chem (2007) 0.89
Decreased sputum mature dendritic cells in healthy smokers and patients with chronic obstructive pulmonary disease. Int Arch Allergy Immunol (2009) 0.89
Long-term omalizumab treatment in severe allergic asthma: the South-Eastern Mediterranean "real-life" experience. Pulm Pharmacol Ther (2011) 0.89
Angiogenic molecule Tie-2 and VEGF in the pathogenesis of pleural effusions. Respir Med (2008) 0.88
Investigation of bone marrow mesenchymal stem cells (BM MSCs) involvement in Idiopathic Pulmonary Fibrosis (IPF). Respir Med (2010) 0.88
C-reactive protein evolution in obstructive sleep apnoea patients under CPAP therapy. Eur J Clin Invest (2010) 0.88
Effect of Mediterranean diet versus prudent diet combined with physical activity on OSAS: a randomised trial. Eur Respir J (2011) 0.88
Different activity of the biological axis VEGF-Flt-1 (fms-like tyrosine kinase 1) and CXC chemokines between pulmonary sarcoidosis and idiopathic pulmonary fibrosis: a bronchoalveolar lavage study. Clin Dev Immunol (2010) 0.88
Intrapleural fibrinolytic therapy for pleural infection. Pulm Pharmacol Ther (2006) 0.87
Altered surfactant protein-A expression in type II pneumocytes in COPD. Chest (2009) 0.87
Different angiogenic CXC chemokine levels in bronchoalveolar lavage fluid after interferon gamma-1b therapy in idiopathic pulmonary fibrosis patients. Pulm Pharmacol Ther (2008) 0.87
Expression analysis of Akt and MAPK signaling pathways in lung tissue of patients with idiopathic pulmonary fibrosis (IPF). J Recept Signal Transduct Res (2010) 0.87
Oxidative DNA damage and somatic mutations: a link to the molecular pathogenesis of chronic inflammatory airway diseases. Chest (2011) 0.86
Bronchial artery embolization for management of massive cryptogenic hemoptysis: a case series. J Med Case Rep (2011) 0.86
Effects of antifibrotic agents on TGF-beta1, CTGF and IFN-gamma expression in patients with idiopathic pulmonary fibrosis. Respir Med (2007) 0.86
Detection of herpes simplex virus type-1 in patients with fibrotic lung diseases. PLoS One (2011) 0.85
Molecular pathways and genetic factors in the pathogenesis of laryngopharyngeal reflux. Eur Arch Otorhinolaryngol (2009) 0.84
Pulmonary involvement and allergic disorders in inflammatory bowel disease. World J Gastroenterol (2010) 0.84
Investigation of angiogenetic axis Angiopoietin-1 and -2/Tie-2 in fibrotic lung diseases: a bronchoalveolar lavage study. Int J Mol Med (2010) 0.84
Sputum and nasal lavage lung-specific biomarkers before and after smoking cessation. BMC Pulm Med (2011) 0.84
Diagnostic value of interleukin-1alpha, interleukin-6, and tumor necrosis factor in pleural effusions. Chest (2002) 0.84
Detection and genotype analysis of human papillomavirus in non-small cell lung cancer patients. Tumour Biol (2013) 0.84
Th1/Th2 cytokine pattern in bronchoalveolar lavage fluid and induced sputum in pulmonary sarcoidosis. BMC Pulm Med (2005) 0.84
DNA damage due to oxidative stress in Chronic Obstructive Pulmonary Disease (COPD). Int J Mol Sci (2012) 0.83
Microsatellite DNA instability in benign lung diseases. Respir Med (2005) 0.83
Investigation of Toll-like receptors in the pathogenesis of fibrotic and granulomatous disorders: a bronchoalveolar lavage study. Fibrogenesis Tissue Repair (2010) 0.83
Translation and validation of Berlin questionnaire in primary health care in Greece. BMC Pulm Med (2013) 0.83
Expression of FACIT collagens XII and XIV during bleomycin-induced pulmonary fibrosis in mice. Anat Rec A Discov Mol Cell Evol Biol (2003) 0.82
Quality of life in patients with active sarcoidosis in Greece. Eur J Intern Med (2006) 0.82
Immune and genetic mechanisms in COPD: possible targets for therapeutic interventions. Curr Drug Targets (2013) 0.82
Lymphangiogenesis in COPD: another link in the pathogenesis of the disease. Respir Med (2011) 0.82
Continuous positive airway pressure therapy lowers vagal tone in patients with obstructive sleep apnoea-hypopnoea syndrome. Hellenic J Cardiol (2006) 0.82
8-Isoprostane, a marker of oxidative stress, is increased in the expired breath condensate of patients with pulmonary sarcoidosis. Chest (2004) 0.82
Prediction of obstructive sleep apnea syndrome in a large Greek population. Sleep Breath (2010) 0.81
Laser-assisted uvulopalatoplasty for the treatment of snoring and mild obstructive sleep apnea syndrome. J Otolaryngol (2003) 0.81
The angiogenetic pathway in malignant pleural effusions: Pathogenetic and therapeutic implications. Exp Ther Med (2010) 0.81
Effect of Mediterranean diet on lipid peroxidation marker TBARS in obese patients with OSAHS under CPAP treatment: a randomised trial. Sleep Breath (2011) 0.80
Histological expression of angiogenic factors: VEGF, PDGFRalpha, and HIF-1alpha in Hodgkin lymphoma. Pathol Res Pract (2008) 0.80
Role of VEGF-stromal cell-derived factor-1alpha/CXCL12 axis in pleural effusion of lung cancer. J Recept Signal Transduct Res (2010) 0.80
A patient presenting with bilateral lung lesions, pleural effusion, and proteinuria. Case Rep Med (2013) 0.79
Laboratory markers for COPD in "susceptible" smokers. Clin Chim Acta (2005) 0.79
The challenge of acute exacerbation of pulmonary fibrosis. Respiration (2011) 0.79
Sarcoidosis in a 65-year-old woman presenting with a lung mass and pericardial effusion: a case report. J Med Case Rep (2012) 0.79
Airway inflammation and cellular stress in noneosinophilic atopic asthma. Chest (2006) 0.79
Short telomeres and treatment of pulmonary fibrosis: implications for early intervention. Am J Respir Crit Care Med (2009) 0.79